Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The Parkinson’s Foundation estimates that 15,000 people in Wisconsin have Parkinson’s disease. And that number is only ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making ... are detected in blood once symptoms have started in Lewy's body diseases, ... July 23, 2024 — Researchers ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...